GlassScriptPhysician profile
Diane Low
NPI 1831835883
$3,214.90
in general payments reported to CMS, 2019-2025
15 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $399 · 2023: $568 · 2024: $903 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,729 · Travel and Lodging: $87.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,728.77 |
| Travel and Lodging | $87.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $492.27 | 2023-2025 | Novosorb Btm |
| Skeletal Dynamics INC | $408.71 | 2025 | Ijs, Align, Geminus |
| Sanara Medtech INC. | $400.93 | 2023-2024 | Celleraterx |
| Aroa Biosurgery Incorporated | $375.98 | 2025 | |
| Si-Bone, INC. | $314.56 | 2023-2024 | |
| Stryker Corporation | $205.15 | 2025 | Gamma, Pangea |
| Kuros Biosciences USA, INC | $158.34 | 2024 | Magnetos |
| Novus Surgical Consultants | $157.81 | 2022-2025 | |
| Cerapedics INC. | $135.85 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Endo Pharmaceuticals INC. | $123.48 | 2022 | |
| Treace Medical Concepts, INC. | $123.14 | 2025 | |
| Axogen | $114.29 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Arthrex, INC. | $102.69 | 2025 | |
| Integra Lifesciences Corporation | $65.64 | 2022 | |
| Restor3d, INC. | $36.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.